{"html": "<div class=\"lf-doc\"><p class=\"lf-p\">N04AA01 03-0123-02 Parkopan 2 SZ tabletes 2 100 1,05 1,43 1,40 1,26 1,05 0,70 A 31.12.2007.</p>\n<p class=\"lf-p\">Trimeperidinum N02AX 96-0192-01 Promedols 2% KS šķīdums injekcijām 20mg/ml-1ml 10 4,20 5,47 5,47 4,92 4,10 2,74 B 30.06.2008.</p>\n<p class=\"lf-p\">Triptorelinum L02AE04 98-0005-01 Diphereline 3.75mg BF pulveris injekcijām ar šķīdinātāju 3,75 1 91,10 100,12 100,12 90,11 75,09 50,06 B 30.06.2008.</p>\n<p class=\"lf-p\">L02AE04 03-0240-01 Diphereline S.R. 11.25mg BF pulveris injekcijām ar šķīdinātāju 11,25 1 255,52 272,76 272,76 245,48 204,57 136,38 B 31.12.2008.</p>\n<p class=\"lf-p\">Vaccinum influenzae J07BB01 05-0097-01 Influvac SV suspensija injekcijām pilnšļircē 15mcgx3/0,5ml 1 2,68 3,54 3,54 3,19 2,66 1,77 A R 14.11.2008.</p>\n<p class=\"lf-p\">J07BB01 95-0283-01 Vaxigrip SA suspensija injekcijām pilnšļircē 15mcgx3/0,5ml 1 3,45 4,56 3,54 3,19 2,66 1,77 A 04.12.2008.</p>\n<p class=\"lf-p\">J07BB01 05-0197-01 Fluarix GK suspensija injekcijām pilnšļircē 15mcgx3/0,5ml 1 3,80 4,99 3,54 3,19 2,66 1,77 A 14.11.2008.</p>\n<p class=\"lf-p\">J07BB01 02-0120-01 Vaxigrip for pediatric use SA suspensija injekcijām pilnšļircē 7,5mcgx3/0,25ml 1 3,06 4,07 4,07 3,66 3,05 2,04 A R 04.12.2008.</p>\n<p class=\"lf-p\">Valganciclovirum J05AB14 05-0128-01 Valcyte 450mg RO apvalkotas tabletes 450 60 1096,37 1155,65 1155,65 1040,09 866,74 577,83 B 31.12.2007.</p>\n<p class=\"lf-p\">Valsartanum C09CA03 02-0391-01 Diovan 80 NV apvalkotas tabletes 80 28 12,86 15,80 13,31 11,98 9,98 6,66 A 31.12.2007.</p>\n<p class=\"lf-p\">C09CA03 02-0392-01 Diovan 160 NV apvalkotas tabletes 160 28 15,87 19,25 15,74 14,17 11,81 7,87 A 31.12.2007.</p>\n<p class=\"lf-p\">Valsartanum/ Hydrochloro­thiazidum C09DA03 98-0310-01 Co-Diovan 80/12,5 NV apvalkotas tabletes 80/12,5 28 12,86 15,80 13,16 11,84 9,87 6,58 A 31.12.2007.</p>\n<p class=\"lf-p\">C09DA03 02-0393-01 Co-Diovan 160/12,5 NV apvalkotas tabletes 160/12,5 28 15,87 19,25 15,23 13,71 11,42 7,62 A 31.12.2007.</p>\n<p class=\"lf-p\">C09DA03 02-0394-01 Co-Diovan 160/25 NV apvalkotas tabletes 160/25 28 15,87 19,25 17,11 15,40 12,83 8,56 A 31.12.2007.</p>\n<p class=\"lf-p\">Venlafaxinum N06AX16 05-0556-01 Velaxin 37,5mg EG tabletes 37,5 28 3,75 4,92 4,92 4,43 3,69 2,46 A R 30.06.2008.</p>\n<p class=\"lf-p\">N06AX16 03-0165-01 Venlaxor 37,5mg GS tabletes 37,5 30 4,23 5,51 5,27 4,74 3,95 2,64 A 31.12.2008.</p>\n<p class=\"lf-p\">N06AX16 05-0558-01 Velaxin 75mg EG tabletes 75 28 6,67 8,47 8,47 7,62 6,35 4,24 A R 30.06.2008.</p>\n<p class=\"lf-p\">N06AX16 00-0032-01 Efexor XR 75 WL ilgstošas darbības kapsulas 75 28 16,43 19,88 10,17 9,15 7,63 5,09 A 31.03.2008.</p>\n<p class=\"lf-p\">N06AX16 03-0166-01 Venlaxor 75mg GS tabletes 75 30 7,49 9,46 9,08 8,17 6,81 4,54 A 31.12.2008.</p>\n<p class=\"lf-p\">N06AX16 00-0033-01 Efexor XR 150 WL ilgstošas darbības kapsulas 150 28 28,29 33,02 20,31 18,28 15,23 10,16 A 31.03.2008.</p>\n<p class=\"lf-p\">Verapamilum C08DA01 96-0522-01 Lekoptin 40mg LK apvalkotas tabletes 40 50 0,74 1,01 1,01 0,91 0,76 0,51 A R 31.12.2007.</p>\n<p class=\"lf-p\">C08DA01 98-0345-02 Verapamil-ratiopharm N 80 RP apvalkotas tabletes 80 50 1,61 2,16 2,00 1,80 1,50 1,00 A 31.12.2007.</p>\n<p class=\"lf-p\">C08DA01 98-0227-01 Isoptin retard AB ilgstošas darbības tabletes 120 20 2,17 2,89 1,44 1,30 1,08 0,72 A 31.12.2007.</p>\n<p class=\"lf-p\">C08DA01 98-0227-02 Isoptin retard AB ilgstošas darbības tabletes 120 100 7,90 9,96 7,15 6,44 5,36 3,58 A 31.12.2007.</p>\n<p class=\"lf-p\">C08DA01 98-0228-01 Isoptin retard AB ilgstošas darbības tabletes 240 20 4,89 6,32 2,86 2,57 2,15 1,43 A 31.12.2007.</p>\n<p class=\"lf-p\">C08DA01 98-0228-02 Isoptin retard AB ilgstošas darbības tabletes 240 100 11,53 14,26 14,20 12,78 10,65 7,10 A 30.06.2008.</p>\n<p class=\"lf-p\">Verapamilum/ Trandolaprilum C08DA51 98-0522-01 Tarka AB kapsulas 180/2 28 7,44 9,41 8,43 7,59 6,32 4,22 A 30.06.2008.</p>\n<p class=\"lf-p\">Vinblastinum L01CA01 99-0776-01 Vinblastine-Teva 10mg TE pulveris injekciju šķīduma pagatavošanai 10 1 8,27 10,41 10,41 9,37 7,81 5,21 B 30.06.2008.</p>\n<p class=\"lf-p\">L01CA02 99-0766-01 Vincristine-Teva 1mg/ml TE šķīdums injekcijām 1mg/ml 1 2,62 3,45 3,45 3,11 2,59 1,73 B 30.06.2008.</p>\n<p class=\"lf-p\">Vinorelbinum L01CA04 99-0347-04 Navelbine 10mg/ml PR koncentrāts infūziju šķīduma pagatavošanai 10mg/ml 1 19,59 23,43 23,43 21,09 17,57 11,72 B 31.12.2008.</p>\n<p class=\"lf-p\">L01CA04 99-0349-02 Navelbine 50mg/5ml PR koncentrāts infūziju šķīduma pagatavošanai 50mg/5ml 1 94,87 104,08 104,08 93,67 78,06 52,04 B 31.12.2008.</p>\n<p class=\"lf-p\">Warfarinum B01AA03 00-0042-01 Orfarin 3mg OR tabletes 3 100 1,93 2,58 2,34 2,11 1,76 1,17 A 30.06.2008.</p>\n<p class=\"lf-p\">B01AA03 00-1030-01 Varfarīns- Grindeks GS tabletes 3 100 1,74 2,34 2,34 2,11 1,76 1,17 A R 31.12.2007.</p>\n<p class=\"lf-p\">B01AA03 00-0043-01 Orfarin 5mg OR tabletes 5 100 2,34 3,11 2,81 2,53 2,11 1,41 A 30.06.2008.</p>\n<p class=\"lf-p\">B01AA03 00-1031-01 Varfarīns- Grindeks GS tabletes 5 100 2,11 2,81 2,81 2,53 2,11 1,41 A R 31.12.2007.</p>\n<p class=\"lf-p\">Ziprasidonum N05AE04 02-0269-08 Zeldox PF kapsulas 40 60 74,80 83,00 83,00 74,70 62,25 41,50 B 31.03.2009.</p>\n<p class=\"lf-p\">N05AE04 02-0270-08 Zeldox PF kapsulas 60 60 88,59 97,48 97,48 87,73 73,11 48,74 B 31.03.2009.</p>\n<p class=\"lf-p\">N05AE04 02-0271-08 Zeldox PF kapsulas 80 60 117,50 127,84 127,84 115,06 95,88 63,92 B 31.12.2007.</p>\n<p class=\"lf-p\">Zuclopenthixolum N05AF05 02-0056-01 Cisordinol 10mg LU apvalkotas tabletes 10 50 4,97 6,42 6,42 5,78 4,82 3,21 B 31.12.2008.</p>\n<p class=\"lf-p\">N05AF05 02-0057-01 Cisordinol 25mg LU apvalkotas tabletes 25 50 6,76 8,58 8,58 7,72 6,44 4,29 B 31.12.2008.</p>\n<p class=\"lf-p\">N05AF05 96-0260-01 Cisordinol Depot 200mg/ml LU šķīdums injekcijām 200mg/ml 1 2,34 3,11 3,11 2,80 2,33 1,56 B 31.12.2008.</p>\n<p class=\"lf-p\">VIII faktora koncentrāts B02BD02 99-1017-01 Dried Factor VIII Fraction Type 8Y BP pulveris injekcijām 250SV/10ml 10 28,48 33,23 33,23 29,91 24,92 16,62 B 30.06.2008.</p>\n<p class=\"lf-p\">B02BD02 99-1017-02 Dried Factor VIII Fraction Type 8Y BP pulveris injekcijām 500SV/20ml 20 57,64 64,98 64,98 58,48 48,74 32,49 B 30.06.2008.</p>\n<p class=\"lf-p\">B02BD02 05-0497-01 Immunate Baxter 250 IU BX pulveris injekcijām ar šķīdinātāju 250SV/ 5ml 5 32,63 37,81 37,81 34,03 28,36 18,91 B 30.09.2007.</p>\n<p class=\"lf-p\">B02BD02 05-0498-01 Immunate Baxter 500 IU BX pulveris injekcijām ar šķīdinātāju 500SV/ 5 ml 5 65,06 72,78 72,78 65,50 54,59 36,39 B 30.09.2007.</p>\n<p class=\"lf-p\">B02BD02 05-0499-01 Immunate Baxter 1000 IU BX pulveris injekcijām ar šķīdinātāju 1000SV/10ml 10 130,04 141,00 141,00 126,90 105,75 70,50 B 30.09.2007.</p>\n<p class=\"lf-p\">IX faktora koncentrāts B02BD04 02-0204-01 Immunine BX pulveris injekcijām ar šķīdinātāju 600SV/5ml 5 164,27 176,95 176,95 159,26 132,71 88,48 B 31.03.2008.</p>\n<p class=\"lf-p\">B02BD04 02-0205-01 Immunine BX pulveris injekcijām ar šķīdinātāju 1200SV/10ml 10 328,54 349,43 349,43 314,49 262,07 174,72 B 31.03.2008.</p>\n<p class=\"lf-p\">B02BD04 02-0035-01 Replenine-VF BP pulveris injekcijām ar šķīdinātāju 1000SV/20ml 20 122,24 132,81 132,81 119,53 99,61 66,41 B 30.06.2008.</p>\n<p class=\"lf-p\">B02BD04 02-0034-01 Replenine-VF BP pulveris injekcijām ar šķīdinātāju 500SV/10ml 10 61,35 68,88 68,88 61,99 51,66 34,44 B 30.06.2008.</p>\n<p class=\"lf-p\">Saīsinājums Ražotājfirmas nosaukums AB Abbott Laboratories S.A.;</p>\n<p class=\"lf-p\">Abbott GmbH AC Alcon Laboratories, Inc AD AWD Pharma GmbH&amp;Co.KG, AWD Pharma SIA AE Astellas Pharma Europe B.V.</p>\n<p class=\"lf-p\">AF Alpharma Ltd.</p>\n<p class=\"lf-p\">AG Amgen Europe B.V.</p>\n<p class=\"lf-p\">AL s.a. Alcon-Couvreur n.v.</p>\n<p class=\"lf-p\">AS Asta Medica AG AT Actavis Nordic A/S AV Aventis Pharma, Laboratoire Aventis AZ AstraZeneca BC Berlin-Chemie AG/Menarini Group BF Beaufour IPSEN International BG Biogen IDEC Limited BM Bristol-Myers Squibb S.p.A.</p>\n<p class=\"lf-p\">BO Boehringer Ingelheim Intern.</p>\n<p class=\"lf-p\">GmbH BP Bioproducts Laboratory BX Baxter AG CA Chauvin ankerpharm GmbH CG Chugai-Aventis CH Chinoin Pharmaceutical and Chemical Works CP Cipla Ltd DF Dr. Falk Pharma GmbH EG EGIS Pharmaceuticals Ltd EL Eli Lilly &amp; Co.Ltd EV SIA Elvim Latvija EW Ebewe Pharma GmbH, EBEWE Arzneimittel GmbH FE Ferring AB; Ferring A/S FS Fujisawa GmbH GK Glaxo Group, GlaxoSmithKline GN Genericon Pharma GmbH GP GEROT Pharmazeutika GmbH GR Chemical Works of Gedeon Richter Ltd, Gedeon Richter Ltd.</p>\n<p class=\"lf-p\">GS PAS \"Grindeks\", AS \"Grindeks\"</p>\n<p class=\"lf-p\">HE Helsinn Birex Pharmaceutical Ltd HL Hexal AG IL Ipsen Limited IV IVAX JC Janssen-Cilag International JP Janssen Pharmaceutica N.V.</p>\n<p class=\"lf-p\">JO UAB Johnson&amp;Johnson KR KRKA KS A/S \" Kalceks\"</p>\n<p class=\"lf-p\">LA Lab. Alacan, S.A.</p>\n<p class=\"lf-p\">LB Laboratorios Inkeysa S.A.</p>\n<p class=\"lf-p\">LC Lečiva a.s.</p>\n<p class=\"lf-p\">LE Leo Pharmaceutical Products LF Lab. Fournier S.C.A.</p>\n<p class=\"lf-p\">LH Lannacher Heilmittel GmbH LI Lilly France S.A., Lilly S.A.</p>\n<p class=\"lf-p\">LK LEK Pharmaceutical and Chemical Company LL Les Laboratoires Servier LM Lusofarmaco/Menarini Group LU H. Lundbeck A/S MA Medice Arzneimittel Putter GmbH&amp;Co.KG MC Medochemie Ltd.</p>\n<p class=\"lf-p\">MF Mepha Lda MK Merck KgaA; Merck Sante s.a.s.</p>\n<p class=\"lf-p\">MN A. Menarini Pharm. Ind.</p>\n<p class=\"lf-p\">Group.Ltd.; Menarini International Operations Luxembourg S.A.</p>\n<p class=\"lf-p\">MP Mundipharma GmbH MS Merck Sharp &amp; Dohme, SIA \"Merck Sharp &amp; Dohme Latvija\"</p>\n<p class=\"lf-p\">MZ Merz+Co GmbH NB NaPro BioTherapeutics Ltd.</p>\n<p class=\"lf-p\">NC Nycomed NF Novartis Finland Oy NK Nippon Kayaku Co., Ltd NL Napp Laboratories Ltd., Napp Pharmaceuticals Ltd.</p>\n<p class=\"lf-p\">NR Norton Healthcare Limited NO Novo Nordisk A/S NP Novartis Pharma S.A.S.</p>\n<p class=\"lf-p\">NV Novartis Pharma AG, Novartis Europharm Ltd OL A/S \"Olainfarm\"</p>\n<p class=\"lf-p\">OR Orion Corporation PB Pabianice Pharmaceutical Works \"Polfa\"</p>\n<p class=\"lf-p\">PF Pfizer Limited, Pfizer Enterprises SAR PI ICN Polfa Rzeszow S.A.</p>\n<p class=\"lf-p\">PL Pliva, Pliva Krakow Pharmaceutical Company S.A, Pliva Pharmaceutical Industry, SIA Pliva PM Pro.Med.CS Praha a.s.</p>\n<p class=\"lf-p\">PN Pronova Biocare a.s.</p>\n<p class=\"lf-p\">PO Pharmaceutical Works \"Polpharma\" S.A.</p>\n<p class=\"lf-p\">PR Pierre Fabre Medicament PT Tarchomin Pharmac. Works Polfa;</p>\n<p class=\"lf-p\">Polfa Tarchomin S.A PU Pharmacia &amp; Upjohn;</p>\n<p class=\"lf-p\">Pharmacia N.V./S.A., Pharmacia AB RA Ranbaxy Laboratories Ltd;</p>\n<p class=\"lf-p\">Ranbaxy UK Ltd RO F. Hoffmann-La Roche Ltd.</p>\n<p class=\"lf-p\">RP Ratiopharm GmbH RR Roche Registration Limited SA Sanofi Pasteur S.A.</p>\n<p class=\"lf-p\">SBr Sanofi Pharma Bristol-Myers SB SmithKline Beecham plc SC Schering AG SE Serono Europe Ltd SF Sanofi-Synthelabo France SI Sicor Biotech UAB SM Smaller S.A.</p>\n<p class=\"lf-p\">SN Santen Oy SO Schering Oy SP Schering-Plough Europe SR Schwarz Pharma AG SV Solvay Pharmaceuticals SZ Sandoz Pharma Ltd; Sandoz GmbH TE TEVA Pharmaceutical Industries Ltd, Teva Pharma B.V.</p>\n<p class=\"lf-p\">UF SIA \"Unifarma\"</p>\n<p class=\"lf-p\">UM Unimed Pharma Ltd.</p>\n<p class=\"lf-p\">VF VIFOR (International) Inc.</p>\n<p class=\"lf-p\">WE Wyeth Europa Ltd WL Wyeth-Lederle Pharma GmbH WP Worwag Pharma GmbH WY Wyeth Whitehall Export GmbH YA Yamanouchi Europe B.V.</p>\n<p class=\"lf-p\">ZE Zentiva a.s.</p>\n<p class=\"lf-p\">Zāļu cenu valsts aģentūras direktores vietniece I.Mauriņa 2. pielikums Zāļu cenu valsts aģentūras 2007.gada 4.jūnija rīkojumam Nr.13 Kompensējamo medicīnisko ierīču saraksts 1 2 3 4 5 6 7 8 10 11 12 13 14 15 Medicīniskā ierīce Identifi-kācijas Nr.</p>\n<p class=\"lf-p\">Medicīniskās ierīces nosaukums Reģistrācijas apliecības īpašnieks Iepako-juma lielums Kom-pen- sācijas bāzes cena (Ls) Aptie-kas cena ar PVN (Ls) Refe-rences cena ar PVN (Ls) 100% Kompensācijas summa Saraksta kategorija Pazīme Iekļaušanas termiņš 90% 75% 50% 1 2 3 4 5 6 7 8 10 11 12 13 14 15 Glikēmijas teststrēmeles 003802-03 Accu-Chek Active Roche Diagnostics GmbH 50 11,60 14,34 14,34 12,91 10,76 7,17 B 30.06.2008.</p>\n<p class=\"lf-p\">030176-02 Glucocard II Test Strip ARKRAY,Inc 50 11,08 13,74 13,74 12,37 10,31 6,87 B 30.09.2007.</p>\n<p class=\"lf-p\">050158-01 Glucocard X Sensor ARKRAY,Inc 25 5,71 7,32 7,32 6,59 5,49 3,66 B 31.12.2008.</p>\n<p class=\"lf-p\">040659-02 Glukometra Accu-Chek Go teststrēmeles Roche Diagnostics GmbH 50 11,60 14,34 14,34 12,91 10,76 7,17 B 31.12.2007.</p>\n<p class=\"lf-p\">050609-05 Glukometra CareSens teststrēmeles Ravemma, SIA 50 10,29 12,83 12,83 11,55 9,62 6,42 B 30.06.2008.</p>\n<p class=\"lf-p\">030056-02 Glukometra IME teststrēmeles IME-Medical Equipment 50 10,70 13,30 13,30 11,97 9,98 6,65 B 30.06.2009.</p>\n<p class=\"lf-p\">050557-01 MediSense Optium Plus Electrodes Abbott Laboratories S.A.</p>\n<p class=\"lf-p\">25 5,60 7,18 7,18 6,46 5,39 3,59 B 31.12.2008.</p>\n<p class=\"lf-p\">050557-03 MediSense Optium Plus Electrodes Abbott Laboratories Baltics SIA 50 11,60 14,34 14,34 12,91 10,76 7,17 B 31.12.2008.</p>\n<p class=\"lf-p\">030687-01 MediSense Sensor Electrodes Abbott Laboratories Baltics SIA 50 10,90 13,53 13,53 12,18 10,15 6,77 B 31.12.2008.</p>\n<p class=\"lf-p\">000266-03 Supreme SIA Ravemma 50 10,70 13,30 13,30 11,97 9,98 6,65 B 31.12.2008.</p>\n<p class=\"lf-p\">Inkontinences līdzekļi 050413-15 EURON FLEX super TAMRO MedLab SIA 28 4,42 5,74 5,74 5,17 4,31 2,87 B 31.12.2007.</p>\n<p class=\"lf-p\">050413-01 EURON FORM super M TAMRO MedLab SIA 28 7,77 9,81 9,81 8,83 7,36 4,91 B 31.12.2007.</p>\n<p class=\"lf-p\">050413-03 EURON FORM super L TAMRO MedLab SIA 28 8,81 11,06 11,06 9,95 8,30 5,53 B 31.12.2007.</p>\n<p class=\"lf-p\">050413-05 EURON FORM super XL TAMRO MedLab SIA 14 5,15 6,64 6,64 5,98 4,98 3,32 B 31.12.2007.</p>\n<p class=\"lf-p\">050413-11 EURON MOBI super M TAMRO MedLab SIA 14 6,21 7,92 7,92 7,13 5,94 3,96 B 31.12.2007.</p>\n<p class=\"lf-p\">050413-13 EURON MOBI super L TAMRO MedLab SIA 14 6,60 8,39 8,39 7,55 6,29 4,20 B 31.12.2007.</p>\n<p class=\"lf-p\">050413-07 EURON WINGS super M TAMRO MedLab SIA 14 4,34 5,65 5,65 5,09 4,24 2,83 B 31.12.2007.</p>\n<p class=\"lf-p\">050413-09 EURON WINGS super L TAMRO MedLab SIA 14 4,80 6,22 6,22 5,60 4,67 3,11 B 31.12.2007.</p>\n<p class=\"lf-p\">004234-01 Molicare M Magnum Medical SIA 28 5,99 7,65 7,65 6,89 5,74 3,83 B 31.12.2007.</p>\n<p class=\"lf-p\">004234-03 Molicare L Magnum Medical SIA 28 7,16 9,06 9,06 8,15 6,80 4,53 B 31.12.2007.</p>\n<p class=\"lf-p\">031158-01 SENI Super small SIA \"Bella Rīga\"</p>\n<p class=\"lf-p\">10 1,90 2,55 2,55 2,30 1,91 1,28 B 31.03.2008.</p>\n<p class=\"lf-p\">031158-03 SENI Super medium SIA \"Bella Rīga\"</p>\n<p class=\"lf-p\">10 2,08 2,78 2,78 2,50 2,09 1,39 B 31.03.2008.</p>\n<p class=\"lf-p\">031158-05 SENI Super large SIA \"Bella Rīga\"</p>\n<p class=\"lf-p\">10 2,56 3,38 3,38 3,04 2,54 1,69 B 31.03.2008.</p>\n<p class=\"lf-p\">050282-16 TENA FLEX maxi S SCA Hygiene Products SIA 22 8,25 10,38 10,38 9,34 7,79 5,19 B 30.06.2008.</p>\n<p class=\"lf-p\">050282-17 TENA FLEX maxi M SCA Hygiene Products SIA 22 8,34 10,49 10,49 9,44 7,87 5,25 B 31.12.2007.</p>\n<p class=\"lf-p\">050282-20 TENA FLEX maxi L SCA Hygiene Products SIA 22 9,96 12,44 12,44 11,20 9,33 6,22 B 31.12.2007.</p>\n<p class=\"lf-p\">050282-23 TENA FLEX maxi XL SCA Hygiene Products SIA 21 11,41 14,12 14,12 12,71 10,59 7,06 B 31.12.2007.</p>\n<p class=\"lf-p\">050282-01 TENA FLEX plus S SCA Hygiene Products SIA 30 7,52 9,50 9,50 8,55 7,13 4,75 B 30.06.2008.</p>\n<p class=\"lf-p\">050282-02 TENA FLEX plus M SCA Hygiene Products SIA 30 7,67 9,68 9,68 8,71 7,26 4,84 B 31.12.2007.</p>\n<p class=\"lf-p\">050282-05 TENA FLEX plus L SCA Hygiene Products SIA 30 9,14 11,46 11,46 10,31 8,60 5,73 B 31.12.2007.</p>\n<p class=\"lf-p\">050282-07 TENA FLEX super S SCA Hygiene Products SIA 28 8,54 10,73 10,73 9,66 8,05 5,37 B 30.06.2008.</p>\n<p class=\"lf-p\">050282-08 TENA FLEX super M SCA Hygiene Products SIA 28 8,63 10,84 10,84 9,76 8,13 5,42 B 31.12.2007.</p>\n<p class=\"lf-p\">050282-11 TENA FLEX super L SCA Hygiene Products SIA 28 10,18 12,71 12,71 11,44 9,53 6,36 B 31.12.2007.</p>\n<p class=\"lf-p\">050282-14 TENA FLEX super XL SCA Hygiene Products SIA 28 12,22 15,06 15,06 13,55 11,30 7,53 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-08 TENA PANTS plus XS SCA Hygiene Products SIA 11 6,64 8,44 8,44 7,60 6,33 4,22 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-11 TENA PANTS plus S SCA Hygiene Products SIA 14 6,41 8,16 8,16 7,34 6,12 4,08 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-14 TENA PANTS plus M SCA Hygiene Products SIA 14 6,91 8,77 8,77 7,89 6,58 4,39 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-17 TENA PANTS plus L SCA Hygiene Products SIA 14 7,82 9,86 9,86 8,87 7,40 4,93 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-20 TENA PANTS plus XL SCA Hygiene Products SIA 12 7,66 9,67 9,67 8,70 7,25 4,84 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-23 TENA PANTS super S SCA Hygiene Products SIA 12 7,18 9,09 9,09 8,18 6,82 4,55 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-26 TENA PANTS super M SCA Hygiene Products SIA 12 7,66 9,67 9,67 8,70 7,25 4,84 B 31.12.2007.</p>\n<p class=\"lf-p\">040301-29 TENA PANTS super L SCA Hygiene Products SIA 12 8,63 10,84 10,84 9,76 8,13 5,42 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-23 TENA SLIP maxi S SCA Hygiene Products SIA 22 6,32 8,05 8,05 7,25 6,04 4,03 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-26 TENA SLIP maxi M SCA Hygiene Products SIA 22 7,37 9,32 9,32 8,39 6,99 4,66 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-29 TENA SLIP maxi L SCA Hygiene Products SIA 22 8,95 11,22 11,22 10,10 8,42 5,61 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-02 TENA SLIP plus XS SCA Hygiene Products SIA 30 5,48 7,04 7,04 6,34 5,28 3,52 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-05 TENA SLIP plus S SCA Hygiene Products SIA 30 6,21 7,92 7,92 7,13 5,94 3,96 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-08 TENA SLIP plus M SCA Hygiene Products SIA 30 6,93 8,79 8,79 7,91 6,59 4,40 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-11 TENA SLIP plus L SCA Hygiene Products SIA 30 8,46 10,64 10,64 9,58 7,98 5,32 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-14 TENA SLIP super S SCA Hygiene Products SIA 25 6,58 8,37 8,37 7,53 6,28 4,19 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-17 TENA SLIP super M SCA Hygiene Products SIA 25 7,25 9,18 9,18 8,26 6,89 4,59 B 31.12.2007.</p>\n<p class=\"lf-p\">030200-20 TENA SLIP super L SCA Hygiene Products SIA 25 8,70 10,93 10,93 9,84 8,20 5,47 B 31.12.2007.</p>\n<p class=\"lf-p\">Krājtelpa medikamentu inhalācijām 060101-01 Aerochamber Plus Adult GlaxoSmithKline Latvia SIA 1 9,05 11,35 11,35 10,22 8,51 5,68 B 31.12.2008.</p>\n<p class=\"lf-p\">060101-03 Aerochamber Plus Child GlaxoSmithKline Latvia SIA 1 10,65 13,25 13,25 11,93 9,94 6,63 B 31.12.2008.</p>\n<p class=\"lf-p\">060101-05 Aerochamber Plus Infant GlaxoSmithKline Latvia SIA 1 10,65 13,25 13,25 11,93 9,94 6,63 B 31.12.2008.</p>\n<p class=\"lf-p\">Stomas aprūpes preces 030259-20 Combihesive 2S Durahesive Convex pamatnes 22/45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 12,90 15,84 15,84 14,26 11,88 7,92 B 31.12.2008.</p>\n<p class=\"lf-p\">030259-21 Combihesive 2S Durahesive Convex pamatnes 25/45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 12,90 15,84 15,84 14,26 11,88 7,92 B 31.12.2008.</p>\n<p class=\"lf-p\">030259-22 Combihesive 2S Durahesive Convex pamatnes 28/45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 12,90 15,84 15,84 14,26 11,88 7,92 B 31.12.2008.</p>\n<p class=\"lf-p\">030259-23 Combihesive 2S Durahesive Convex pamatnes 32/45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 12,90 15,84 15,84 14,26 11,88 7,92 B 31.12.2008.</p>\n<p class=\"lf-p\">030259-24 Combihesive 2S Durahesive Convex pamatnes 35/45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 12,90 15,84 15,84 14,26 11,88 7,92 B 31.12.2008.</p>\n<p class=\"lf-p\">030259-25 Combihesive 2S Durahesive Convex pamatnes 38/57mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 12,90 15,84 15,84 14,26 11,88 7,92 B 31.12.2008.</p>\n<p class=\"lf-p\">030259-01 Combihesive 2S elastīgās pamatnes 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-02 Combihesive 2S elastīgās pamatnes 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-03 Combihesive 2S elastīgās pamatnes 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-04 Combihesive 2S elastīgās pamatnes 57mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-05 Combihesive 2S elastīgās pamatnes 70mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">031353-05 Esteem Synergy elastīgās pamatnes 48mm Bristol-Myers Sqibb Polska Sp.z.o.o 5 13,16 16,15 10,72 9,65 8,04 5,36 A 30.06.2009.</p>\n<p class=\"lf-p\">031353-07 Esteem Synergy elastīgās pamatnes 61mm Bristol-Myers Sqibb Polska Sp.z.o.o 5 13,16 16,15 10,72 9,65 8,04 5,36 A 30.06.2009.</p>\n<p class=\"lf-p\">030260-01 Combihesive 2S Ileostomas maisiņi 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 6,41 8,16 8,16 7,34 6,12 4,08 A R 31.03.2008.</p>\n<p class=\"lf-p\">030260-35 Combihesive 2S Ileostomas maisiņi Invisi Close 32mm Bristol-Myers Squibb Polska Sp.z.o.o 10 14,15 17,29 8,16 7,34 6,12 4,08 A 30.06.2008.</p>\n<p class=\"lf-p\">030260-02 Combihesive 2S Ileostomas maisiņi 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 6,41 8,16 8,16 7,34 6,12 4,08 A R 31.03.2008.</p>\n<p class=\"lf-p\">030260-36 Combihesive 2S Ileostomas maisiņi Invisi Close 38mm Bristol-Myers Squibb Polska Sp.z.o.o 10 14,15 17,29 8,16 7,34 6,12 4,08 A 30.06.2008.</p>\n<p class=\"lf-p\">030260-03 Combihesive 2S Ileostomas maisiņi 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 6,41 8,16 8,16 7,34 6,12 4,08 A R 31.03.2008.</p>\n<p class=\"lf-p\">030260-37 Combihesive 2S Ileostomas maisiņi Invisi Close 45mm Bristol-Myers Squibb Polska Sp.z.o.o 10 14,15 17,29 8,16 7,34 6,12 4,08 A 30.06.2008.</p>\n<p class=\"lf-p\">030260-04 Combihesive 2S Ileostomas maisiņi 57mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 6,41 8,16 8,16 7,34 6,12 4,08 A R 31.03.2008.</p>\n<p class=\"lf-p\">030260-38 Combihesive 2S Ileostomas maisiņi Invisi Close 57mm Bristol-Myers Squibb Polska Sp.z.o.o 10 14,15 17,29 8,16 7,34 6,12 4,08 A 30.06.2008.</p>\n<p class=\"lf-p\">030260-05 Combihesive 2S Ileostomas maisiņi 70mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 6,41 8,16 8,16 7,34 6,12 4,08 A R 31.03.2008.</p>\n<p class=\"lf-p\">031353-13 Esteem Synergy slēgti ileostomas maisiņi ar filtru 48mm Bristol-Myers Sqibb Polska Sp.z.o.o 10 18,83 22,58 8,16 7,34 6,12 4,08 A 30.06.2009.</p>\n<p class=\"lf-p\">031353-15 Esteem Synergy slēgti ileostomas maisiņi ar filtru 61mm Bristol-Myers Sqibb Polska Sp.z.o.o 10 18,83 22,58 8,16 7,34 6,12 4,08 A 30.06.2009.</p>\n<p class=\"lf-p\">030260-06 Combihesive 2S Ileostomas maisiņi 100mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 8,91 11,18 11,18 10,06 8,39 5,59 B 31.03.2008.</p>\n<p class=\"lf-p\">030260-39 Combihesive 2S Ileostomas maisiņi Invisi Close 70mm Bristol-Myers Squibb Polska Sp.z.o.o 10 14,15 17,29 8,16 7,34 6,12 4,08 A 30.06.2008.</p>\n<p class=\"lf-p\">030260-20 Combihesive 2S kolostomas maisiņi ar filtru 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-21 Combihesive 2S kolostomas maisiņi ar filtru 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-22 Combihesive 2S kolostomas maisiņi ar filtru 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-23 Combihesive 2S kolostomas maisiņi ar filtru 57mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-24 Combihesive 2S kolostomas maisiņi ar filtru 70mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-31 Combihesive 2S Little Ones drenējamie maisiņi 32mm Bristol-Myers Squibb Polska Sp.z.o.o 10 11,83 14,61 14,61 13,15 10,96 7,31 B 31.12.2008.</p>\n<p class=\"lf-p\">030259-30 Combihesive 2S Little Ones pamatnes 32mm Bristol-Myers Squibb Polska Sp.z.o.o 5 11,83 14,61 14,61 13,15 10,96 7,31 B 31.12.2008.</p>\n<p class=\"lf-p\">030260-10 Combihesive 2S Std kolostomas maisiņi 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-11 Combihesive 2S Std kolostomas maisiņi 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-12 Combihesive 2S Std kolostomas maisiņi 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-13 Combihesive 2S Std kolostomas maisiņi 57mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">030260-14 Combihesive 2S Std kolostomas maisiņi 70mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 12,72 15,63 15,63 14,07 11,72 7,82 A R 31.12.2008.</p>\n<p class=\"lf-p\">031353-09 Esteem Synergy slēgti kolostomas maisiņi ar filtru 48mm Bristol-Myers Sqibb Polska Sp.z.o.o 30 37,07 42,70 15,63 14,07 11,72 7,87 A 30.06.2009.</p>\n<p class=\"lf-p\">031353-11 Esteem Synergy slēgti kolostomas maisiņi ar filtru 61mm Bristol-Myers Sqibb Polska Sp.z.o.o 30 37,07 42,70 15,63 14,07 11,72 7,87 A 30.06.2009.</p>\n<p class=\"lf-p\">030259-11 Combihesive 2S Stomahesive pamatnes 32mm Bristol-Myers Squibb Polska Sp.z.o.o 5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-12 Combihesive 2S Stomahesive pamatnes 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-13 Combihesive 2S Stomahesive pamatnes 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-14 Combihesive 2S Stomahesive pamatnes 57mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-15 Combihesive 2S Stomahesive pamatnes 70mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 8,53 10,72 10,72 9,65 8,04 5,36 A R 31.12.2008.</p>\n<p class=\"lf-p\">030259-16 Combihesive 2S Stomahesive pamatnes 100mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">5 11,68 14,44 14,44 13,00 10,83 7,22 B 31.03.2008.</p>\n<p class=\"lf-p\">031353-01 Esteem Synergy Stomahesive pamatnes 48mm Bristol-Myers Sqibb Polska Sp.z.o.o 5 13,16 16,15 10,72 9,65 8,04 5,36 A 30.06.2009.</p>\n<p class=\"lf-p\">031353-03 Esteem Synergy Stomahesive pamatnes 61mm Bristol-Myers Sqibb Polska Sp.z.o.o 5 13,16 16,15 10,72 9,65 8,04 5,36 A 30.06.2009.</p>\n<p class=\"lf-p\">030260-30 Combihesive 2S Urostomas maisiņi 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,95 13,60 13,60 12,24 10,20 6,80 B 30.06.2009.</p>\n<p class=\"lf-p\">030260-31 Combihesive 2S Urostomas maisiņi 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,95 13,60 13,60 12,24 10,20 6,80 B 30.06.2009.</p>\n<p class=\"lf-p\">030260-32 Combihesive 2S Urostomas maisiņi 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,95 13,60 13,60 12,24 10,20 6,80 B 30.06.2009.</p>\n<p class=\"lf-p\">030260-33 Combihesive 2S Urostomas maisiņi 57mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,95 13,60 13,60 12,24 10,20 6,80 B 30.06.2009.</p>\n<p class=\"lf-p\">030260-34 Combihesive 2S Urostomas maisiņi 70mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,95 13,60 13,60 12,24 10,20 6,80 B 30.06.2009.</p>\n<p class=\"lf-p\">060211-01 Esteem viendaļīgi ileostomas maisiņi 20mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 11,53 14,26 14,26 12,83 10,70 7,13 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-05 Esteem viendaļīgi ileostomas maisiņi 30mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 11,53 14,26 14,26 12,83 10,70 7,13 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-07 Esteem viendaļīgi ileostomas maisiņi 40mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 11,53 14,26 14,26 12,83 10,70 7,13 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-09 Esteem viendaļīgi ileostomas maisiņi 50mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 11,53 14,26 14,26 12,83 10,70 7,13 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-11 Esteem viendaļīgi ileostomas maisiņi 60mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 11,53 14,26 14,26 12,83 10,70 7,13 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-25 Esteem Small kolostomas maisiņi 20mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 26,01 30,51 30,51 27,46 22,88 15,26 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-13 Esteem viendaļīgi kolostomas maisiņi 20mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 26,01 30,51 30,51 27,46 22,88 15,26 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-15 Esteem viendaļīgi kolostomas maisiņi 25mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 26,01 30,51 30,51 27,46 22,88 15,26 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-17 Esteem viendaļīgi kolostomas maisiņi 30mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 26,01 30,51 30,51 27,46 22,88 15,26 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-19 Esteem viendaļīgi kolostomas maisiņi 40mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 26,01 30,51 30,51 27,46 22,88 15,26 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-21 Esteem viendaļīgi kolostomas maisiņi 50mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 26,01 30,51 30,51 27,46 22,88 15,26 B 31.12.2008.</p>\n<p class=\"lf-p\">060211-23 Esteem viendaļīgi kolostomas maisiņi 60mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 26,01 30,51 30,51 27,46 22,88 15,26 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-27 Stomadress Plus viendaļīgi ileostomas maisiņi 19mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,76 13,38 13,38 12,04 10,04 6,69 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-28 Stomadress Plus viendaļīgi ileostomas maisiņi 25mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,76 13,38 13,38 12,04 10,04 6,69 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-29 Stomadress Plus viendaļīgi ileostomas maisiņi 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,76 13,38 13,38 12,04 10,04 6,69 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-30 Stomadress Plus viendaļīgi ileostomas maisiņi 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,76 13,38 13,38 12,04 10,04 6,69 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-31 Stomadress Plus viendaļīgi ileostomas maisiņi 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 10,76 13,38 13,38 12,04 10,04 6,69 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-01 Stomadress Plus viendaļīgi kolostomas maisiņi 19mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 21,49 25,53 25,53 22,98 19,15 12,77 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-02 Stomadress Plus viendaļīgi kolostomas maisiņi 25mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 21,49 25,53 25,53 22,98 19,15 12,77 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-03 Stomadress Plus viendaļīgi kolostomas maisiņi 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 21,49 25,53 25,53 22,98 19,15 12,77 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-04 Stomadress Plus viendaļīgi kolostomas maisiņi 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 21,49 25,53 25,53 22,98 19,15 12,77 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-05 Stomadress Plus viendaļīgi kolostomas maisiņi 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 21,49 25,53 25,53 22,98 19,15 12,77 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-06 Stomadress Plus viendaļīgi kolostomas maisiņi 50mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30 21,49 25,53 25,53 22,98 19,15 12,77 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-20 Stomadress Plus viendaļīgi urostomas maisiņi 19mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 16,75 20,23 20,23 18,21 15,17 10,12 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-21 Stomadress Plus viendaļīgi urostomas maisiņi 32mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 16,75 20,23 20,23 18,21 15,17 10,12 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-22 Stomadress Plus viendaļīgi urostomas maisiņi 38mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 16,75 20,23 20,23 18,21 15,17 10,12 B 31.12.2008.</p>\n<p class=\"lf-p\">030261-23 Stomadress Plus viendaļīgi urostomas maisiņi 45mm Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">10 16,75 20,23 20,23 18,21 15,17 10,12 B 31.12.2008.</p>\n<p class=\"lf-p\">060209-03 Stomahesive adhezīvā pasta Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">30g 2,42 3,20 3,20 2,88 2,40 1,60 B 31.12.2008.</p>\n<p class=\"lf-p\">060209-01 Stomahesive adhezīvais pūderis Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">25g 2,38 3,16 3,16 2,84 2,37 1,58 B 31.12.2008.</p>\n<p class=\"lf-p\">060209-05 Stomahesive ādu aizsārgājoša pasta Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">60g 4,85 6,27 6,27 5,64 4,70 3,14 B 31.12.2008.</p>\n<p class=\"lf-p\">060209-07 ConvaCare plāksnītes adhezīva noņemšanai Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">100 7,30 9,24 9,24 8,32 6,93 4,62 B 31.12.2008.</p>\n<p class=\"lf-p\">060209-09 ConvaCare plāksnītes aizsargkārtas veidošanai Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">100 7,30 9,24 9,24 8,32 6,93 4,62 B 31.12.2008.</p>\n<p class=\"lf-p\">060209-11 Josta lietošanai ar Combihesive 2S stomu maisiņiem Bristol-Myers Squibb Polska Sp.z.o.o.</p>\n<p class=\"lf-p\">1 2,17 2,89 2,89 2,60 2,17 1,45 B 31.12.2008.</p>\n<p class=\"lf-p\">Zāļu cenu valsts aģentūras direktores vietniece I.Mauriņa</p></div>", "next": 0}